RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Quarter Return
+65.08%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$190M
AUM Growth
+$69.9M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 93.5%
2 Communication Services 6.43%
3 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$114M 60.06%
3,766,666
TVRD
2
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
$42.4M 22.29%
77,752
MRSN icon
3
Mersana Therapeutics
MRSN
$35.6M
$21.2M 11.15%
31,858
LVO icon
4
LiveOne
LVO
$66.3M
$12.2M 6.43%
3,724,138
SENS icon
5
Senseonics Holdings
SENS
$375M
$139K 0.07%
159,601